Forecasting The Future: 10 Analyst Projections For Health Catalyst

Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Health Catalyst HCAT in the last three months.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $7.2, a high estimate of $10.00, and a low estimate of $4.00. Observing a downward trend, the current average is 22.16% lower than the prior average price target of $9.25.

Understanding Analyst Ratings: A Comprehensive Breakdown

The analysis of recent analyst actions sheds light on the perception of Health Catalyst by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

| Analyst | Analyst Firm | Action Taken | Rating |Current Price Target| Prior Price Target | |--------------------|--------------------|---------------|---------------|--------------------|--------------------| |Elizabeth Anderson |Evercore ISI Group |Lowers |In-Line | $4.00|$6.00 | |Jeff Garro |Stephens & Co. |Lowers |Equal-Weight | $5.00|$7.00 | |Sean Dodge |RBC Capital |Lowers |Sector Perform | $6.00|$7.00 | |David Grossman |Stifel |Lowers |Hold | $5.00|$10.00 | |Jeff Garro |Stephens & Co. |Maintains |Equal-Weight | $7.00|$7.00 | |Jessica Tassan |Piper Sandler |Lowers |Overweight | $8.00|$12.00 | |Stan Berenshteyn |Wells Fargo |Lowers |Overweight | $10.00|$13.00 | |Richard Close |Canaccord Genuity |Lowers |Buy | $10.00|$11.00 | |Sean Dodge |RBC Capital |Lowers |Sector Perform | $7.00|$9.00 | |Daniel Grosslight |Citigroup |Lowers |Buy | $10.00|$10.50 |

Key Insights:

• Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Health Catalyst. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Health Catalyst compared to the broader market.
• Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Health Catalyst's stock. This comparison reveals trends in analysts' expectations over time.

For valuable insights into Health Catalyst's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on Health Catalyst analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

All You Need to Know About Health Catalyst

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Financial Insights: Health Catalyst

Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.

Revenue Growth: Health Catalyst's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 6.02%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Health Catalyst's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -25.97% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Health Catalyst's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -5.74% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Health Catalyst's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -2.47%, the company showcases efficient use of assets and strong financial health.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.1.

How Are Analyst Ratings Determined?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.